EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Complement-Based Therapy in the Management of Antibody-Mediated Rejection

Anshul Bhalla, Nada Alachkar, Sami Alasfar

Advances in Chronic Kidney Disease · 2020-03 · 27 (2) · 138-148

DOI: 10.1053/j.ackd.2019.12.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Chronic Kidney Disease, 2020-03. Verfasst von Anshul Bhalla und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Transplant Surgery, Department of Surgery, James D. Eason Transplant Institute, Methodist University Hospital, University of Tennessee He…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Complement C1 Inhibitor Protein, Complement Pathway, Classical, Graft Rejection. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: CareDx, Shire ViroPharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedComplement C1 Inhibitor ProteinComplement Pathway, ClassicalGraft RejectionComplement Inactivating AgentsHLA AntigensHumansKidney Failure, ChronicKidney Transplantation

Stichwörter der Autor:innen

C1 esterase inhibitorComplementEculizumabRejectionTransplant

Substanzen

Antibodies, Monoclonal, HumanizedComplement C1 Inhibitor ProteinComplement Inactivating AgentsHLA Antigenseculizumab

Autor:innen und Institutionen

  • Division of Transplant Surgery, Department of Surgery, James D. Eason Transplant Institute, Methodist University Hospital, University of Tennessee Health Science Center, Memphis, TN.
  • Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address: salasfa1@jhmi.edu.

Förderung

  • CareDx
  • Shire ViroPharma

Zitieren

APA

Bhalla, A., Alachkar, N., & Alasfar, S. (2020). Complement-Based Therapy in the Management of Antibody-Mediated Rejection. Advances in Chronic Kidney Disease, 27(2), 138-148. https://doi.org/10.1053/j.ackd.2019.12.002

Vancouver

Bhalla A, Alachkar N, Alasfar S. Complement-Based Therapy in the Management of Antibody-Mediated Rejection. Advances in Chronic Kidney Disease. 2020;27(2):138-148. doi:10.1053/j.ackd.2019.12.002

BibTeX
@article{Bhalla2020,
  author = {Bhalla, Anshul and Alachkar, Nada and Alasfar, Sami},
  title = {Complement-Based Therapy in the Management of Antibody-Mediated Rejection},
  journal = {Advances in Chronic Kidney Disease},
  year = {2020},
  volume = {27},
  number = {2},
  pages = {138--148},
  doi = {10.1053/j.ackd.2019.12.002}
}
Kostenlos starten →